The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive ...

This study provides valuable insight into the increasing use of obesity drugs. The rising prescription numbers suggest that ...

The General Pharmaceutical Council (GPhC) have published the new guidance for prescribing weight loss injections such as ...

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.

The General Pharmaceutical Council (GPhC) has introduced new rules for weight-loss jabs, such as Wegovy and Mounjaro, in ...

A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans. © 2024 Fortune Media IP Limited. All Rights ...

Copyright 2025 The Associated Press. All Rights Reserved. A new poll from The Associated Press-NORC Center for Public Affairs Research looks at what U.S. adults think ...

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other ... dollars each time you fill a prescription.

Now, a new study finds that Ozempic, along with similar drugs such as Wegovy, has had a broad “economic and societal impact” because of “noticeable shifts in dietary behavior.” The study ...

Amid a new year boom in demand the National Pharmacy Association (NPA ... its effect size emerged , compared to the "gorilla" of Wegovy. The two biggest selling GLP-1 drugs are branded as Wegovy ...